{"id":"https://openalex.org/W2106489628","doi":null,"title":"Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.","display_name":"Molecular and pharmacokinetic properties associated with the therapeutics of bcl-2 antisense oligonucleotide G3139 combined with free and liposomal doxorubicin.","publication_year":2000,"publication_date":"2000-07-01","ids":{"openalex":"https://openalex.org/W2106489628","mag":"2106489628","pmid":"https://pubmed.ncbi.nlm.nih.gov/10914739"},"language":"en","primary_location":{"id":"pmid:10914739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10914739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079602516","display_name":"D E Lopes de Menezes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D E Lopes de Menezes","raw_affiliation_strings":["Department of Advanced Therapeutics, British Columbia Cancer Research Centre, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Advanced Therapeutics, British Columbia Cancer Research Centre, Vancouver, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047623272","display_name":"Norma J. Hudon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N Hudon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089253181","display_name":"N L McIntosh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N McIntosh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110146267","display_name":"L.D. Mayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L D Mayer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.986,"has_fulltext":false,"cited_by_count":93,"citation_normalized_percentile":{"value":0.92167355,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"6","issue":"7","first_page":"2891","last_page":"902"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.948199987411499,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.023900000378489494,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcl-2-antisense-oligonucleotide","display_name":"Bcl-2 antisense oligonucleotide","score":0.9269999861717224},{"id":"https://openalex.org/keywords/g3139","display_name":"G3139","score":0.9789999723434448},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9430000185966492},{"id":"https://openalex.org/keywords/liposomal-doxorubicin","display_name":"liposomal doxorubicin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6859999895095825},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.6819999814033508},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5529999732971191},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.746999979019165},{"id":"https://openalex.org/keywords/tumor-drug-accumulation","display_name":"tumor drug accumulation","score":0.7009999752044678},{"id":"https://openalex.org/keywords/breast-cancer-xenografts","display_name":"breast cancer xenografts","score":0.7699999809265137},{"id":"https://openalex.org/keywords/synergistic-antitumor-effect","display_name":"synergistic antitumor effect","score":0.7620000243186951},{"id":"https://openalex.org/keywords/bcl-2-downregulation","display_name":"Bcl-2 downregulation","score":0.7120000123977661}],"concepts":[{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.8091959953308105},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5938209295272827},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5718829035758972},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4797881245613098},{"id":"https://openalex.org/C2776415932","wikidata":"https://www.wikidata.org/wiki/Q48743","display_name":"Western blot","level":3,"score":0.4498148262500763},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.4481213092803955},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4402586817741394},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37577202916145325},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3617475926876068},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3292171359062195},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19074389338493347},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008081","descriptor_name":"Liposomes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016376","descriptor_name":"Oligonucleotides, Antisense","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D016513","descriptor_name":"Mice, SCID","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D019254","descriptor_name":"Genes, bcl-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10914739","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10914739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"mag:2106489628","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10914739","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W20453933","https://openalex.org/W39449442","https://openalex.org/W100870282","https://openalex.org/W112005226","https://openalex.org/W198776403","https://openalex.org/W1543443055","https://openalex.org/W1559053841","https://openalex.org/W1588809288","https://openalex.org/W1591166893","https://openalex.org/W1748388485","https://openalex.org/W1777880772","https://openalex.org/W1936464499","https://openalex.org/W1941582121","https://openalex.org/W1986516374","https://openalex.org/W1990548509","https://openalex.org/W1997569032","https://openalex.org/W2002273265","https://openalex.org/W2027344275","https://openalex.org/W2028065774","https://openalex.org/W2040506871","https://openalex.org/W2042760441","https://openalex.org/W2064059721","https://openalex.org/W2067401769","https://openalex.org/W2084341407","https://openalex.org/W2118878458","https://openalex.org/W2135368384","https://openalex.org/W2136885844","https://openalex.org/W2140383812","https://openalex.org/W2156246685","https://openalex.org/W2158449037","https://openalex.org/W2161580101","https://openalex.org/W2162464751","https://openalex.org/W2170314391","https://openalex.org/W2259568108","https://openalex.org/W2321782282","https://openalex.org/W2330056755","https://openalex.org/W4214917010"],"related_works":["https://openalex.org/W2094042165","https://openalex.org/W2111254733","https://openalex.org/W2438277306","https://openalex.org/W2151650355","https://openalex.org/W1972267510","https://openalex.org/W2028016023","https://openalex.org/W2092820019","https://openalex.org/W4042391","https://openalex.org/W1996146233","https://openalex.org/W2232535406"],"abstract_inverted_index":{"Bcl-2":[0,31,103,114,135,155,298],"is":[1,306],"a":[2,15,62,109],"key":[3],"apoptosis-regulating":[4],"protein":[5,115],"that":[6,52,190,214,278,294],"has":[7],"been":[8],"implicated":[9],"in":[10,88,164,226,288],"mechanisms":[11],"of":[12,17,29,71,79,90,102,105,112,120,127,134,143,151,161,176,186,194,200,204,207,229,262,268,283,297,311],"chemoresistance":[13],"for":[14],"variety":[16],"malignancies":[18],"by":[19,241],"blocking":[20],"programmed":[21],"cell":[22,129],"death.":[23,130],"This":[24,231],"study":[25],"investigated":[26],"the":[27,30,50,77,91,113,132,141,149,184,195,205,227,251,260,281],"activity":[28,60,160],"antisense":[32,299],"oligodeoxynucleotide":[33],"(AS":[34],"ODN)":[35],"G3139":[36,72,177,211,242,255],"combined":[37,307],"with":[38,83,124,166,192,209,223,256,308],"free":[39],"doxorubicin":[40,46],"(F-DOX)":[41],"or":[42,169],"sterically":[43],"stabilized":[44],"liposomal":[45,309],"(SL-DOX)":[47],"to":[48,75,137,153,182,273,285],"determine":[49],"role":[51],"drug":[53,217,276],"pharmacodistribution":[54],"properties":[55],"may":[56,301],"have":[57],"on":[58],"antitumor":[59,159,263],"using":[61],"Bcl-2-expressing":[63],"human":[64],"breast":[65],"solid":[66,106,289],"tumor":[67,128,216,252,275],"xenograft":[68],"model.":[69],"Administration":[70],"was":[73,171,180,233,271],"able":[74,181],"delay":[76],"growth":[78,185],"MDA435/LCC6":[80,187],"cells":[81,188],"compared":[82,222],"control":[84],"ODN-treated":[85],"animals;":[86],"however,":[87],"all":[89],"cases,":[92],"tumors":[93,107],"reestablished":[94],"after":[95,116],"AS":[96],"ODN":[97,145,156,162,300],"treatment.":[98,157],"Western":[99],"blot":[100],"analyses":[101],"levels":[104,139,219,238,277],"showed":[108],"sequence-specific":[110,234],"down-regulation":[111],"four":[117],"daily":[118],"doses":[119],"G3139,":[121],"which":[122,147,244],"correlated":[123],"histological":[125],"evidence":[126],"Interestingly,":[131],"expression":[133],"returned":[136],"pretreatment":[138],"during":[140],"course":[142],"subsequent":[144],"administration,":[146],"suggested":[148],"development":[150],"resistance":[152],"continued":[154],"The":[158,174,265],"given":[163,197],"conjunction":[165],"either":[167,193],"F-DOX":[168,179,208],"SL-DOX":[170,257,284],"also":[172],"examined.":[173],"combination":[175,270],"and":[178,235],"suppress":[183],"beyond":[189],"obtained":[191,221,303],"treatments":[196],"alone,":[198],"indicative":[199],"synergistic":[201],"action.":[202],"Examination":[203],"pharmacokinetics":[206],"systemic":[210],"administration":[212],"revealed":[213],"elevated":[215],"DOX":[218,224,237],"were":[220,239],"treatment":[225],"absence":[228],"G3139.":[230],"effect":[232],"plasma":[236],"unaffected":[240],"treatment,":[243],"indicated":[245],"possible":[246],"positive":[247],"ODN-drug":[248],"interactions":[249],"at":[250],"site.":[253],"Combining":[254],"further":[258],"increased":[259,274],"degree":[261],"activity.":[264],"improved":[266],"efficacy":[267],"this":[269],"attributed":[272],"arise":[279],"from":[280],"ability":[282],"passively":[286],"accumulate":[287],"tumors.":[290],"These":[291],"results":[292],"suggest":[293],"additional":[295],"benefits":[296],"be":[302],"when":[304],"it":[305],"formulations":[310],"anticancer":[312],"drugs":[313],"such":[314],"as":[315],"DOX.":[316]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}